ArticleJournal of health, population, and nutrition2025
Global burden of paralytic ileus and intestinal obstruction, 1990-2021: a GBD 2021 analysis.
Article in Journal of health, population, and nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Global, Regional, and National Burden of Acute Abdominal Conditions in Females-Appendicitis, Ectopic Pregnancy, Paralytic Ileus and Intestinal Obstruction, and Urolithiasis, 1990-2021: A Systematic Analysis for the Global Burden of Disease Study 2021 with ARIMA Projections to 2030.International journal of women's health · 2026Article
- Cross-national pharmacovigilance of drug-induced intestinal obstruction: disproportionality signals in FAERS and external validation in JADER.Frontiers in pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
purposeParalytic ileus and intestinal obstruction (PI&IO) are significant global surgical emergencies associated with high morbidity and mortality. This study aimed to comprehensively assess the global, regional, and national burden of PI&IO from 1990 to 2021.
methodsWe used data from the Global Burden of Diseases Study (GBD) 2021, covering 204 countries and territories. We estimated the number of incident cases and years of life lost (YLLs), along with age-standardized incidence rates (ASIR) and age-standardized YLLs rates (ASYR), each with corresponding 95% uncertainty intervals (UIs). Analyses were stratified by age, sex, region, and Socio-demographic Index (SDI).
resultsIn 2021, there were approximately 15.8 million PI&IO cases (95% UI: 15.2-16.3 million) and 6.5 million YLLs (95% UI: 5.6-7.2 million) globally. The ASIR was 191.9 per 100,000 (95% UI: 185.4-198.8), showing no significant change since 1990. In contrast, the ASYR decreased slightly reaching 82.3 per 100,000 in 2021. Regionally, ASIRs were highest in high-income Asia Pacific, North America, and Australasia, while ASYRs peaked in Eastern and Western Sub-Saharan Africa. Nationally, Canada, Japan, and Cabo Verde had the highest ASIRs, whereas Mozambique, Eritrea, and Somalia reported the highest ASYRs. Age-specific trends revealed a J-shaped incidence curve and a U-shaped YLLs pattern, with the greatest burden in infants under 1 year and adults aged 80 years or older. YLLs in infants have declined steadily over the past three decades. A positive correlation was observed between ASIR and SDI, while ASYR was negatively associated with SDI.
conclusionPI&IO continues to impose a considerable global health burden, with pronounced disparities across regions and socioeconomic contexts. While high-SDI regions experience higher incidence due to enhanced detection, low-SDI countries face persistently high YLLs owing to limited access to timely diagnosis and surgical care. Targeted public health strategies, including early intervention, healthcare infrastructure investment, and policies tailored to vulnerable populations such as infants, the elderly, and residents of low-resource settings, are essential to reduce preventable mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.